Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter
Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter
Background Patient satisfaction with or acceptance of care assessment is increasingly taken
 into account in oncology. Most cancer and other critically-ill patients require a
 totally-implanted Central Venous Catheter (CVC) for their treatment consisting of a reservoir
 connected to a central venous catheter, which may or may not be valved. It is impossible to
 estimate the number of CVC used in oncology. However, some authors claim that, in 2005, over
 7 million CVCs were placed in the United States in both chronic and acute care. Although many
 patients fitted with a CVC are able to undertake activities which are hindered with other
 external vascular access devices, they are often physically or psychologically anxious about
 their device. To our knowledge, no validated questionnaire measuring patient acceptance of
 and satisfaction with their CVC has been reported in the literature. Based on these
 observations, the aim of our study was to develop and to validate a French-language
 questionnaire dubbed QASICC (Questionnaire for Acceptance of and Satisfaction with Implanted
 Central Venous Catheter) assessing patient satisfaction with and acceptance of their CVC.
 QASICC is designed as a multi-dimensional, self-administered questionnaire comprising
 approximately 30 items related to the use, appearance and pros and cons of the device as well
 as quality of life as perceived by patients using one for treatment.

 Objective The purpose of the study is to validate a French-language self-administered
 questionnaire (QASICC) designed to evaluate patients' satisfaction and acceptance concerning
 their totally-implanted central venous catheter: confirmatory validation of questionnaire
 psychometric properties.

 Study Design This is a prospective, multicenter, open study.

 Primary Outcome Measures:

 Questionnaire's 27 items tested on 990 patients to confirm QASICC internal structure:

 -  Items quality

 -  Dimensional structure

 -  Dimensional consistence

 -  Measure accuracy

 -  Measure reliability

 -  Sensitivity to change
QASICC Questionnaire The QASICC questionnaire included 27 questions (Q) assessing seven
 dimensions: pain during placement or use (Q1, Q2), contribution to the comfort of the
 treatment (Q3, Q4, Q7, Q10, Q12), esthetics and privacy (Q5, Q6, Q8, Q11, Q17, Q19), the
 impact on professional activities, social and sports (Q9, Q13, Q14, Q18, Q20), the impact on
 daily activities (Q15, Q16, Q21, Q22 ), local discomfort (Q23, Q24, Q25, Q26) and overall
 satisfaction (Q27). The device-related answers were of two types: Likert or visual analogue
 scale. Four types of Likert response were available: "no", "low," "moderate,"
 "significant,"/"never," "sometimes," "often," "always "/" very easy "," easy "," difficult
 "," very difficult "/" not at all "," somewhat "," a lot "," extremely ". These questions are
 scored 0, 33, 67, 100, respectively, when the scores are correlated with symptoms, or 100,
 67, 33, 0 when the scores are inversely correlated with symptoms. Visual analog scales (VAS)
 have a length of 100 mm. The score represents the number of mm measured on the scale. A mean
 score of acceptance and satisfaction can be calculated on a scale of 0 to 100 for all seven
 dimensions using the following formula: {(100-score DO) + CO + score (score ES-100) + (100-PR
 score) + (100-ES score) + (score 100-IN) + SA score} / 7. The higher the overall score, the
 greater the acceptance and satisfaction

 The questionnaire is administered to the patient 30 days (+/-7 days) after CVC implantation.
Inclusion Criteria:

 -  18 years and older

 -  Patient who benefited or will benefit from the implantation of a CVC

 -  Solid tumor or hematologic malignancy

 -  WHO Performance Status 0-2

 Exclusion Criteria:

 -  Any severe psychopathological disorder preventing completion of the questionnaire or
 invalidating questionnaire's measures

 -  Severe depressive state

 -  Non malignant pathology

 -  Inability to respond to questionnaires

 -  Patient not speaking fluent French

 -  Patient unable to consent

 -  Patient under guardianship